Four specific GLP-1 medications were examined: semaglutide (Wegovy, Ozempic, Rybelsus), liraglutide (Saxenda), exenatide (Byetta, Bydureon BCise), and dulaglutide (Trulicity)
That is often the first sign something went deeper than intended
A 2025 real-world safety comparison found the two drugs had distinct safety profiles, rather than one being safer overall
Given this timeline, waiting for generic semaglutide isnt a practical strategy for people who would benefit from treatment now
La forma inyectable puede ocasionar reacciones en el sitio de inyeccin (enrojecimiento, picazn, hinchazn leve) en aproximadamente 1-3% de pacientes, aunque estas reacciones suelen ser transitorias y leves